Cargando…
Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy
Cardiac hypertrophy is the result of increased myocardial cell size responding to an increased workload and developmental signals. These extrinsic and intrinsic stimuli as key drivers of cardiac hypertrophy have spurred efforts to target their associated signaling pathways. The extracellular signal-...
Autores principales: | Yan, Zhi-Peng, Li, Jie-Ting, Zeng, Ni, Ni, Guo-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169190/ https://www.ncbi.nlm.nih.gov/pubmed/32329039 http://dx.doi.org/10.5603/CJ.a2020.0061 |
Ejemplares similares
-
Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats
por: Miyoshi, Toru, et al.
Publicado: (2019) -
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy
por: Mutlak, Michael, et al.
Publicado: (2015) -
Adipose stem cells enhance myoblast proliferation via acetylcholine and extracellular signal–regulated kinase 1/2 signaling
por: El‐Habta, Roine, et al.
Publicado: (2017) -
The Role of Extracellular Signal-Regulated Kinase Pathways in Different Models of Cardiac Hypertrophy in Rats
por: Moady, Gassan, et al.
Publicado: (2023) -
P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets
por: Gasecka, Aleksandra, et al.
Publicado: (2020)